Another study, done on Chinese subjects, proved that LCN2 serum levels are elevated in patients with NAFLD as opposed to the control and that they highly correlate with both inflammation (C-reactive protein) and insulin resistance [48]. Here, LCN2 is linked to metabolic dysfunction-associated steatotic liver disease.